Agilent Technologies completes acquisition of Silicon Genetics, leading provider of life science informatics
Agilent Technologies Inc. (NYSE: A) today announced the completion of its acquisition of Silicon Genetics, a leading provider of software solutions for life science discovery. Agilent and Silicon Genetics had announced an acquisition agreement Aug. 23, 2004. Financial details of the agreement were not disclosed.
Silicon Genetics, based in Redwood City, Calif., has been recognized as one of the fastest-growing technology companies in North America. Its customers include more than 600 leading pharmaceutical companies, academic institutions and major research organizations around the world. With the addition of Silicon Genetics’ genomics data analysis and management tools to its portfolio, Agilent will become a market leader in life science informatics.
Together, Silicon Genetics and Agilent will form a life science informatics team that will create products spanning DNA, RNA, protein and pathway applications. The team will sell and support the products developed by Silicon Genetics, the Rosetta Resolver and Luminator gene expression data analysis systems, the Agilent Spectrum Mill proteomics workbench and the Agilent Synapsia informatics workbench. The team will also work closely with customers and partners to develop functionality for new life science research applications.
Most of Silicon Genetics’ 50 employees have joined Agilent and are part of the company’s Life Sciences and Chemical Analysis business in Santa Clara, Calif.
More information about the GeneSpring, Signet and Varia products developed by Silicon Genetics is still available online at www.silicongenetics.com.
Agilent in Life Sciences
Agilent’s Life Sciences and Chemical Analysis (LSCA) business is a world-leading provider of instruments, supplies, software and services to the life science and chemical analysis markets. In 2003, these markets accounted for approximately 40 percent and 60 percent respectively of LSCA’s $1.2 billion in revenue. Agilent’s LSCA business is a global organization with 3,700 employees, five international manufacturing sites, and worldwide sales and support services to more than 22,000 customer organizations in more than 70 countries. It is a leading provider of microarray, microfluidic, liquid chromatography, gas chromatography and mass spectrometry-based solutions to pharmaceutical, biotech, academic, government and chemical organizations.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global technology leader in communications, electronics, life sciences and chemical analysis. The company’s 28,000 employees serve customers in more than 110 countries. Agilent had net revenue of $6.1 billion in fiscal year 2003. Information about Agilent is available on the Web at www.agilent.com .
